These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5932052)

  • 21. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Further trials of a long-acting vasodilator agent in 397 patients with cronic peripheral obliterating arteriopathy of a sclerotic nature].
    Ghezzi P; Cavaliere P; Berti Riboli E
    Minerva Cardioangiol; 1969 May; 17(5):333-6. PubMed ID: 5785731
    [No Abstract]   [Full Text] [Related]  

  • 23. The significance of vasodilator therapy in obliterative arterial disease.
    Thulesius O
    Scand J Clin Lab Invest Suppl; 1967; 99():222-4. PubMed ID: 6056925
    [No Abstract]   [Full Text] [Related]  

  • 24. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of vasodilator drugs in arteriosclerosis obliterans.
    Coffman JD; Mannick JA
    Ann Intern Med; 1972 Jan; 76(1):35-9. PubMed ID: 4553743
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 28. [Medical treatment of atherosclerosis obliterans of the lower limbs].
    Ricordeau G
    Rev Prat; 1972 Nov; 22(29):4037-46. PubMed ID: 4649026
    [No Abstract]   [Full Text] [Related]  

  • 29. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
    Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
    Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and hemodynamic effects of captopril in patients with arterial hypertension and obliterative arteriopathy of the legs].
    Bolognini G; Iezzi Biase G
    Clin Ter; 1986 Feb; 116(4):287-9. PubMed ID: 3516544
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pros and cons of vasodilator therapy in obliterative vascular diseases of the lower limbs].
    Thulesius O
    Lakartidningen; 1966 Oct; 63(43):4089-96. PubMed ID: 5977628
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
    Matteoni R; Reale R; Lauri D; Sirolli C; Tata MV
    Minerva Cardioangiol; 1973 Apr; 21(4):264-71. PubMed ID: 4710123
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
    Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
    Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical aspects of using extremely high frequency electromagnetic radiation in the complex treatment of occlusive vascular diseases of the lower extremities].
    Piasetskiĭ VI; Bakharev AM; Driuk NF; Pisanko OA
    Klin Khir (1962); 1991; (7):47-50. PubMed ID: 1942833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Testosterone treatment of obliterative arterial lesions in the legs].
    Hvidt V; Dohn K; Lund J; Nielsen J; Palm L
    Ugeskr Laeger; 1965 Sep; 127(36):1116-23. PubMed ID: 5869540
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
    Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
    Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.